Maintenance Capecitabine Plus Ramucirumab after First-Line Chemotherapy in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Randomized PLATFORM Study.
JCO oncology advances(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined